When does Ping An Healthcare (1833.HK stock) report earnings?

Ping An Healthcare and Technology (1833.HK stock) is scheduled to report earnings on **18 Feb 2026**. Expect commentary on revenue mix, user metrics and margin guidance that can move the share price materially.

What valuation metrics matter for 1833.HK stock?

Key metrics to monitor for 1833.HK stock are PE **142.10**, PB **2.51**, price‑to‑sales **4.99**, free cash flow yield **1.04%**, and current ratio **3.15**. These show high growth expectations but limited cash return today.

What is Meyka AI’s short‑term forecast for 1833.HK stock?

Meyka AI's forecast model projects a near‑term target of **HKD 17.11** for 1833.HK stock, implying about **23.46%** upside from **HKD 13.86**. Forecasts are model‑based projections and not guarantees.

What are the main risks for 1833.HK stock around earnings?

Main risks for 1833.HK stock include disappointing margins, weaker user monetization, adverse regulatory comments, and any guidance cut. High valuation amplifies downside on a negative surprise.

HK Stocks

1833.HK Ping An Healthcare HKSE -3.08% pre-market Feb 2026: earnings risks

ByDanny Kontos February 13, 2026February 13, 2026

1833.HK stock opened the Hong Kong pre-market on 13 Feb 2026 at HKD 13.86, down 3.08% as investors position ahead of Ping An Healthcare and Technology’s scheduled earnings on 18 Feb 2026. The pullback follows a one‑month drop of 20.48% and leaves the share price near the 200‑day average of HKD 13.57. Key short‑term data to watch before the report include trailing EPS HKD 0.10, a high PE of 142.10, and volume of 9,700,442 shares, which suggests active position adjustments into the release. This earnings spotlight flags revenue cadence, margin direction and guidance as the main price drivers.